BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc. (NASDAQ: EWTX) today announced the pricing of its upsized underwritten public offering of 11,627,907 shares of its common stock at a price to the public of $10.32 per share. All of the shares are to be sold by Edgewise Therapeutics. In addition, Edgewise Therapeutics has granted the underwriters a 30-day … [Read more…]
An innovative and open solution bringing together multiple observation modes for future-proof endoscopic surgery TOKYO–(BUSINESS WIRE)–Olympus Corporation (“Olympus” – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced the launch of VISERA ELITE III, its newest surgical visualization platform that addresses the needs of healthcare professionals (HCPs) for endoscopic procedures across multiple medical … [Read more…]
Following the first U.S. death officially attributed to monkeypox and reported in Los Angeles County, AHF now expands its call for public health officials to ramp up vaccine rollout and prevention messaging nationwide LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF), which has been sharply critical of Los Angeles County leadership in its handling of monkeypox, is … [Read more…]
SEATTLE–(BUSINESS WIRE)–Know Labs, Inc. (OTCQB: KNWN), an emerging leader of non-invasive medical diagnostic technology, today announced that, subject to official authorization and meeting all requirements (including the price requirement) at the time of listing, the Company has been approved to uplist to the NYSE American Exchange in conjunction with an underwritten public offering of the … [Read more…]
Investor Conference Call and KOL Forum From TCT 2022 Discussing DurAVR™ Clinical Data to be Hosted on Sept 19, 2022 at 8AM ET BRISBANE, Australia & EGAN, Minn.–(BUSINESS WIRE)–Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR), a structural heart company developing DurAVR™, the world’s only balloon-expandable, 3D single-piece native shaped aortic valve, announced today … [Read more…]
In less than two years, Gilead has more than doubled the cost of its HIV medication, Descovy, for the lifesaving 340B program from $445.11 in Q3, 2020 to $987.55 in Q2, 2022 AHF will host a protest Wednesday, Sept. 14th targeting Gilead Sciences—”Greediad”—and its investors over its AIDS drug pricing during the Baird Global Healthcare … [Read more…]
MILWAUKEE–(BUSINESS WIRE)–Physicians Realty Trust (NYSE:DOC) (the “Company”), through a joint venture with Dallas, Texas based MedProperties Realty Advisors, LLC (“MedProperties”) is proud to announce the closing of the acquisition of Calko Medical Center. This Class-A, free-standing facility, built in 2013, contains 85,567 rentable square feet, anchored by Maimonides Medical Center and physicians associated with Maimonides, … [Read more…]
DURHAM, N.C.–(BUSINESS WIRE)–#GeneCentric—GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today the poster presentation of further clinical validation data for PurIST℠, a novel RNA-expression test, in collaboration with Tempus. PurIST identifies patients with the classical subtype of pancreatic ductal adenocarcinoma (PDAC) that are likely to experience longer overall survival (OS) … [Read more…]
TUCSON, Ariz.–(BUSINESS WIRE)–P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that P3 Health Partners, LLC dba P3 Health Partners-Arizona (“P3 Arizona”) has acquired the practice of Dr. Leonardo Serfino, M.D., in Sierra Vista, Ariz. Dr. Serfino, who specializes in internal medicine, will continue to support his … [Read more…]
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 18th, 2022, to review third-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion … [Read more…]
